Next James Bond Odds: Who’s the Frontrunner in the 007 Casting Race? (August 2026 Edition)
Somewhere in London this month, a handful of actors are reading Bond dialogue for Denis Villeneuve while the rest of us refresh the odds boards. The screen tests are real, the shortlist is sealed, and producer Amy Pascal says an official announcement by the end of 2026 is “a good bet.” After nearly five years without a 007, the next James Bond odds finally have a clock on them: Callum Turner leads the market at 11/10 (+110) with William Hill, backed by a 35 percent price on Kalshi and 23 percent on Polymarket.
That headline hides a wild eight months. Since our December 2025 update, Paul Mescal has fallen off the board entirely, Tom Holland’s candidacy ran into a reported Marvel contract wall, a 23-year-old named Louis Partridge stormed in at 3/1 out of nowhere, and Henry Cavill (yes, still) just triggered one of the biggest betting surges William Hill says it has ever seen in this market.
The race has also changed character. This is no longer a rumor market drifting on fancasts and tabloid whispers. There is now a dated process: finalist screen tests reportedly happening in August, an announcement window that closes with the year, and a 2027 production start. When a speculative market gets a deadline, prices start meaning something.
Below: the updated board, profiles of all ten leading contenders, where December’s favorites went, why the bookmakers and the prediction markets are telling two different stories, and how to play the endgame without getting steamrolled by the next rumor.
The 2026 Bond Race at a Glance: What Changed Since December
The short version: the field consolidated. In December 2025 the board was a crowded argument between Mescal, Turner, Aaron Taylor-Johnson, and a rotating cast of mid-priced hopefuls. Eight months later, Turner has held the top spot through every refresh, most of his December rivals have drifted or vanished, and the new drama comes from names nobody priced at all last winter.
Here is how the biggest movers look side by side:
Odds Timeline (December 2025 to August 2026)
| Actor | Dec. 2025 Odds | Aug. 2026 Odds | What Changed |
|---|---|---|---|
Callum Turner | +275 (Favorite) | 11/10, +110 (Favorite) | Held the top spot through every refresh; screen-test reports only hardened it. |
Henry Cavill | +600 | 3/1, +300 | An August betting surge cut him from 20/1 to 3/1; prediction markets never moved. |
Louis Partridge | Unlisted | 10/1, +1000 | Stormed in at 3/1 in July as the market’s shock new name, then drifted. |
Aaron Taylor-Johnson | +300 | 6/1, +600 | Drifted at the books, but Kalshi traders still price him top-three at 18 cents. |
Paul Mescal | +200 (Co-favorite) | Off the named board | December’s co-favorite fell out of William Hill’s named field entirely; about 1.7% on Polymarket. |
Bookmaker prices are William Hill’s August 6, 2026 refresh; prediction-market figures were pulled August 10. Odds move fast in this market, so treat every number here as a dated snapshot rather than a live quote.
Why the Board Flipped
1. The Process Got Real
For most of 2025, “Bond casting news” meant anonymous quotes and wishlist reporting. In 2026 it became a schedule. Casting director Nina Gold started meeting actors in the spring, Deadline reported in June that auditions were moving to a next round in August, and Euronews confirmed the search had entered its final stage, with Villeneuve personally calling the actors who made the cut. Roughly five to seven finalists are expected to test this month, though one source puts the number higher.
Markets sharpen when a resolution date appears. The moment Amy Pascal put “end of the year” on the record, every price on the board became a bet with a deadline attached.
2. The Marvel Wall Took Out a Front-Runner
Tom Holland sat on Amazon’s reported early wishlist alongside Jacob Elordi and Harris Dickinson, and he openly called Bond “the pinnacle” for a young British actor. Then came the October 2025 reports that his Spider-Man contract reportedly bars him from taking a competing franchise lead. Nothing official was ever announced, but the market treated it as settled: Holland trades at roughly 2 percent on Polymarket today.
3. Retail Money and Sharp Money Split
The strangest feature of the August board: the bookmakers and the prediction markets no longer agree. William Hill has Cavill at 3/1 on pure betting volume while Kalshi traders price him around 4 cents. One of those two crowds is wrong, and figuring out which is the closest thing this market has to an edge in analysis. We break that down in its own section below.
Top 10 Contenders: Odds, Profiles, and Bet Value
The rankings below blend William Hill’s August 6 board with the prediction-market prices and the casting-process reporting. For each name we ask the same three questions: does he fit what Amazon and Villeneuve are actually building, does the reporting connect him to the room where decisions happen, and is his current price a fair reflection of both?
1. Callum Turner (11/10 | 48% Implied)
Turner took the top spot in October 2025 and simply never gave it back. That kind of staying power is rare in this market: favorites usually burn out within a news cycle or two, but every William Hill refresh this year has had him first, and he leads on Kalshi (35 cents) and Polymarket (23 percent) as well. He is also one of the names rumored, though never confirmed, to be in the August screen-test group.
Profile: 36-year-old Londoner known for Masters of the Air, Eternity, and Apple’s upcoming Neuromancer adaptation.
Why Bond? Working-class London grit under a tailored surface, with the dramatic range a Villeneuve Bond would demand. At 36, he is almost exactly the age Daniel Craig was when he got the call.
Pros:
- Ten straight months as the consensus favorite across books and exchanges
- Fits the grounded, psychological direction the production keeps signaling
- Named in screen-test speculation by multiple outlets
Cons:
- At 11/10 you are paying favorite tax in a race with a sealed shortlist
- Long favoritism invites the classic Bond-market swerve to a surprise pick
Bet Value: Fair, not generous. The 48 percent implied at William Hill sits well above his 35 percent Kalshi price, so the exchanges think the books have over-shortened him.
2. Henry Cavill (3/1 | 25% Implied)
The shock of the summer. Cavill was not even in William Hill’s named field in late July, then a sustained wave of bets forced the book to cut him from 20/1 all the way to 3/1 on August 6. Spokesperson Lee Phelps called it “one of the biggest moves we’ve seen in this market.” Here is the catch: no casting report accompanied the surge, and Kalshi traders barely blinked, still pricing him around 4 cents.
Profile: 43-year-old Jersey native; Man of Steel, The Witcher, and the runner-up to Craig for Casino Royale two decades ago.
Why Bond? He has looked the part since 2005, and the fan constituency that wants him has never gone away.
Pros:
- Has screen-tested for Bond before, in the 2005 Casino Royale search
- Global name recognition no one else on this list can match
Cons:
- At 43 he is the oldest name on the board in a search reportedly built around a decade-plus commitment
- The 3/1 reflects betting volume, not reporting; prediction markets price him as a long shot
Bet Value: Poor at 3/1. When a price moves on money instead of information, you are betting against the sharpest rule in this market: the process reporting has pointed younger all year.
3. Aaron Taylor-Johnson (6/1 | 14% Implied)
The great survivor of this market. Taylor-Johnson has been rumored for, offered (allegedly), and passed over for Bond so many times that his odds have become a mood ring for the whole race. The books have him drifting at 6/1, but Kalshi tells a different story: his 18-cent price there is second only to Turner’s, and traders have kept him top-three all year. Whatever the truth of the old “he turned it down” stories, the smart money refuses to bury him.
Profile: 36, known for Kick-Ass, Bullet Train, Kraven the Hunter, and a long-running Omega ambassadorship.
Why Bond? The most complete action resume in the field, plus the watch-brand partnership that has always felt like a dress rehearsal.
Pros:
- Second-highest price on Kalshi at 18 cents
- Proven franchise-scale physicality
Cons:
- Years of rumors have produced exactly zero confirmed process links
- Absent from the reported screen-test chatter, which centers on newer names
Bet Value: Decent. The gap between his 6/1 book price and his Kalshi price makes him one of the few names where the exchanges are more bullish than the bookies.
4. Jack Lowden (6/1 | 14% Implied)
Nobody’s odds have whipsawed harder. Lowden was out of William Hill’s named field in the July 23 refresh, then back at 6/1 by August 6, and his last trade on Kalshi printed at 13 cents against quieter resting bids. That is what a market looks like when it cannot decide whether an actor is a genuine finalist or just a critic’s dream. His Slow Horses spy credentials remain the best in the field, and the whole “quieter, more grounded Bond” theory of this production fits him like a glove.
Profile: 36-year-old Scot; Slow Horses, Dunkirk, Benediction.
Why Bond? Scottish pedigree in the Connery tradition and more hours of prestige espionage screen time than the rest of the top five combined.
Pros:
- Perfect tonal match for a psychological, espionage-first reboot
- The market keeps pulling him back onto the board every time it drops him
Cons:
- Never named in the screen-test speculation
- The volatility itself suggests money chasing vibes rather than information
Bet Value: Interesting at 6/1 if you believe the Villeneuve-tone theory. Just size for the fact that his price has already round-tripped once this summer.
5. Harris Dickinson (8/1 | 11% Implied)
Dickinson checks the two boxes that matter most: he was on Amazon’s reported original wishlist with Holland and Elordi, and he is one of the four names Euronews floated in connection with the August screen tests. At 30 he sits in the exact age band the production reportedly wanted, and directing Urchin while starring in Babygirl made him the credible-artist pick of the field. Polymarket agrees with the case more than the books do, pricing him around 14 percent against 11 at William Hill.
Profile: 30-year-old East Londoner; Triangle of Sadness, The Iron Claw, Babygirl.
Why Bond? Dangerous charisma with arthouse credibility, young enough to carry the franchise into the 2040s.
Pros:
- On both the reported wishlist and the reported screen-test radar
- The age profile the production has signaled from day one
Cons:
- His directing ambitions may complicate a decade-long franchise lock-in
- Kalshi traders are cooler on him, with last trades around 7 cents
Bet Value: One of the better prices on the board. 8/1 for a name with documented process links is the kind of line that disappears fast if a single screen-test leak names him.
6. Louis Partridge (10/1 | 9% Implied)
The market’s shock arrival. Partridge was not priced anywhere until July 23, when he entered William Hill’s board at 3/1 as outright second favorite, a debut the bookmaker’s own spokesperson called remarkable. He has since drifted to 10/1, and notably neither Kalshi nor Polymarket lists him at all, which tells you the exchanges have seen no reporting to anchor a contract on. Two facts keep the theory alive anyway: at 23 he would be the youngest 007 since George Lazenby, and he stars in House of Guinness for Steven Knight, the man writing Bond 26.
Profile: 23-year-old Londoner; Enola Holmes, Disclaimer, House of Guinness.
Why Bond? If the studio truly wants a decade-plus investment who grows into the tux on screen, he is the purest version of that bet.
The catch: A 3/1 entry that fades to 10/1 in two weeks with no exchange listing looks like a book protecting itself from one-way traffic, not a leak. Fun small-stakes flyer, nothing more, until a screen-test report says his name.
7. Jacob Elordi (12/1 | 8% Implied)
Elordi is the field’s biggest book-versus-exchange split after Cavill, just in the opposite direction. William Hill has him drifting at 12/1, but Kalshi traders hold him at 17 cents, effectively tied with Taylor-Johnson for second, and he had a spell as the bookmakers’ outright favorite earlier this year. The original wishlist reporting had him top-three with Holland and Dickinson, and a version of this search that prizes brooding intensity over polish lands squarely on the Saltburn and Frankenstein star. The complication everyone keeps litigating: he is Australian, and this production has reportedly leaned British.
Profile: 29-year-old Australian; Euphoria, Saltburn, Priscilla, Guillermo del Toro’s Frankenstein.
Why Bond? Six-foot-five, era-defining screen presence, and squarely in the under-30 band the studio reportedly started its search with.
The catch: Lazenby remains the only non-Brit to wear the tux, and the market has never fully priced away the nationality question. Still, 12/1 at the books for a 17-cent Kalshi name is a genuine value gap.
8. Tom Francis (11 Cents on Kalshi)
The wild card with the most credible smoke. Francis, the twentysomething stage star who led Jamie Lloyd’s Sunset Boulevard revival in the West End and on Broadway, was one of the four names Euronews attached to the August screen tests, alongside Turner, Dickinson, and Elordi. He barely registers in bookmaker markets, but Kalshi traders have pushed him to 11 cents, above Dickinson’s last trade there. A near-unknown with serious acting chops and no franchise baggage is precisely the profile casting director Nina Gold has reportedly been meeting.
Profile: British stage breakout; Sunset Boulevard on the West End and Broadway.
Why Bond? The “introduce the world to its next star” playbook, the same one that produced Lazenby, Dalton’s near-misses, and Craig’s shock announcement.
The catch: Zero screen-lead experience. If the studio blinks at handing a nine-figure production to a debut film actor, this evaporates.
9. Scott Rose-Marsh (2 Cents on Kalshi)
The only man on this list confirmed by a major trade to have screen-tested for this production. The Hollywood Reporter revealed in August 2025 that Rose-Marsh, a little-known British actor in his late thirties, read scenes from GoldenEye for the production, with one instruction: do not impersonate a previous Bond. William Hill briefly priced him as short as 8/1 in July before he slipped back into the 14/1-bar territory, and Kalshi has him at 2 cents. The test proves the production genuinely considers unknowns; the fade suggests his moment may have passed as the finalist round took shape.
Profile: Late-30s British character actor; Krays: Code of Silence, Wolves of War.
Why Bond? He is the proof of concept for the “total unknown” outcome, and he has already been in the room.
The catch: A year-old screen test with no follow-up reporting is a cold trail. Lottery-ticket pricing for a lottery-ticket case.
10. Henry Ashton (4 Cents on Kalshi)
Ashton is the cautionary tale of 2026’s middle innings. In May, Kalshi traders ran the A Knight of the Seven Kingdoms and My Lady Jane actor up to 16 cents, briefly making him the market’s third choice while the Scotsman tracked bookmakers slashing his price. Three months later he trades at 4 cents on thin quotes. No denial, no report, no scandal: the finalist-stage reporting simply moved to other names, and the air went out. Every Bond cycle produces one of these surges; the lesson is to ask what actual information is underneath before you chase.
Profile: English actor; HBO’s A Knight of the Seven Kingdoms, My Lady Jane, A Good Girl’s Guide to Murder.
Why Bond? Period-drama polish, the right unknown-but-rising profile, and a genuine constituency among traders earlier this year.
The catch: The market has already voted with three months of fade. Only worth a dart if his name resurfaces in test reporting.
Where December’s Favorites Went
Eight months ago this article led with a very different cast. The turnover since then is the single best illustration of how brutal this market is to narrative momentum.
Paul Mescal: From Co-Favorite to Off the Board
In December, Mescal’s +200 was the shortest price on the board and this article called him the best value in the market. That aged badly. As the process reporting took over in 2026, his name simply never appeared in it, and the market drew its own conclusion: he is absent from William Hill’s August named field and trades around 1.7 percent on Polymarket. The Gladiator II heat was real; the connection to this production evidently was not.
Theo James: Dropped by the Books, Not by Traders
The May 2025 favorite has now been cut from William Hill’s named field entirely. Curiously, Kalshi traders have not fully given up, keeping him in the 8-cent range, above several actors the books still price. At 41, with The White Lotus and The Monkey behind him, James remains everyone’s idea of what Bond looks like. The market has just concluded that looking the part was never the assignment.
Tom Holland: The Contract Nobody Can See Past
Holland’s case died differently: not by fade but by reported legal fact. The October 2025 stories that his Spider-Man deal bars a competing franchise lead were never officially confirmed, but with his Marvel commitments running through Spider-Man: Brand New Day and beyond, the market stopped arguing. He sits at roughly 2 percent on Polymarket and lumps in with the 14/1 “bar” field at William Hill, and he has spent the year gamely deflecting the question in interviews.
The Rest of the December Board
- James Norton – out of William Hill’s named field; still trades in the high single digits on both exchanges as the perennial “safe” option.
- Regé-Jean Page – the 2021-era favorite now sits around 5 cents on Kalshi; the market moved on when the production’s profile skewed younger and grittier.
- Jonathan Bailey – a huge 2025 (Wicked, Jurassic World Rebirth) never translated into Bond traction; a few cents on Kalshi.
December’s fashionable long shots followed the same arc: Anthony Boyle, Leo Woodall, and James Nelson-Joyce have all dropped off the listed boards entirely. In this market, a name that stops appearing in process reporting stops existing.
Bookmakers vs. Prediction Markets: Two Very Different Reads
The same race is trading at three very different sets of prices right now, and the differences are more instructive than any single number. Here is the board across William Hill, Polymarket, and Kalshi as of August 10:
| Actor | William Hill (Aug. 6) | Polymarket (Aug. 10) | Kalshi (Aug. 10) |
|---|---|---|---|
| Callum Turner | 11/10 (48%) | 23% | 35¢ |
| Henry Cavill | 3/1 (25%) | 5% | 4¢ |
| Aaron Taylor-Johnson | 6/1 (14%) | 7% | 18¢ |
| Jack Lowden | 6/1 (14%) | 11% | 13¢ |
| Harris Dickinson | 8/1 (11%) | 14% | 7¢ |
| Louis Partridge | 10/1 (9%) | Not listed | Not listed |
| Jacob Elordi | 12/1 (8%) | 9% | 17¢ |
Implied percentages are converted from William Hill’s fractional prices without removing the bookmaker’s margin. Polymarket figures are midpoint prices; Kalshi figures are last trades. Every number is a dated snapshot.
Three structural things explain most of the gaps, and understanding them will make you a smarter bettor in any entertainment market:
The Deadline Changes the Bet
Polymarket’s market asks whether an actor is announced by December 31, 2026, and a separate contract on nobody being announced by then trades around 22 cents. So Turner’s 23 percent there is really a bet on two things at once: Turner getting the part and Amazon confirming it inside the window. Kalshi’s contracts run all the way to 2030, which is why its Turner price sits 12 points higher. Neither market is mispriced; they are answering different questions. William Hill’s odds carry no deadline at all, plus a healthy margin: add up its eight quoted prices and you get roughly 136 percent, which is the book’s edge baked into a novelty market.
The Cavill Test Case
When a bookmaker slashes a price from 20/1 to 3/1 and the exchanges do not move, you are watching sentiment and information trade at different venues. William Hill’s own announcement attributes the Cavill cut to betting volume, full stop. Kalshi traders, who profit by being right rather than by balancing a book, kept him at a nickel. History sides with the traders here: every previous Cavill surge in this market has been a fan wave, not a leak. If real casting information existed, the exchanges would have moved first, the way they did when Turner took over the top spot last fall.
Listing Gaps Are Information Too
Partridge being second-favorite territory at a UK book while neither US exchange lists him tells you his support is retail money responding to media coverage, not traders anticipating an announcement. Watch whether Kalshi adds him: the exchange added George MacKay to its 25-name roster as recently as July 30, so a Partridge listing would signal that traders finally see something worth pricing. For a deeper comparison of how the two exchanges work, our Kalshi vs. Polymarket breakdown covers fees, resolution rules, and liquidity in detail.
One honest caveat on sample size: Polymarket’s Bond market has traded a little over $25,000 in total volume, and Kalshi’s has churned through roughly 1.6 million contracts since launch. These are real prices, but thin ones. A single determined trader can move either board, so read them as a considered crowd estimate rather than gospel.
Behind the Scenes: What the Casting Process Is Telling Us
Strip out the odds entirely and the reporting sketches a surprisingly clear picture of what Bond 26 is becoming, and therefore who fits it.
A Dated, Disciplined Search
Villeneuve is personally phoning the actors who advanced, per Euronews, with screen tests for roughly five to seven finalists reportedly happening this month. Amy Pascal told Deadline in early August that an announcement by the end of 2026 is “a good bet,” with production starting in 2027. Amazon MGM’s film chief Courtenay Valenti spent the spring repeating the same message: the film is coming, and the studio is taking its time. None of this guarantees the timeline holds, but it is the first time since Craig’s exit that the search has had public, dated structure.
Nina Gold and the Unknown-Actor Theory
The casting director running the search built her reputation partly on discovering unknowns, and the reporting says she has been meeting lesser-known names throughout. That is not a rumor pattern; it already produced one confirmed screen test for a near-anonymous actor in Rose-Marsh, and it keeps names like Tom Francis alive on the exchanges. Any bet you place on a household name should account for the real possibility that the answer is someone most people have never heard of.
The Script Points Young
Steven Knight is reportedly drawing on Ian Fleming’s earliest novels, and multiple outlets have described the story as reaching back toward Bond’s Royal Navy years and his rise to 00 status. An origin-flavored reboot argues for an actor who can play the character before the polish, which quietly strengthens the case for the under-32 tier (Dickinson, Elordi, Partridge, Francis) and weakens the nostalgia picks. Villeneuve, for his part, delivers Dune: Part Three in December and has talked about grounding Bond in the psychological weight of the job.
No announcement has been made as of August 10, 2026. Every name in this article is a market read, not a casting report, and the production’s own stated window runs to the end of the year.
Long Shots and Wild Cards Worth Watching
The bottom of the board is where this market pays for attention. A long shot jumping from 2 cents to 15 on a single leak is worth more than a favorite grinding from 11/10 to evens, and Kalshi’s 25-name roster gives the tail of this race more visible structure than it has ever had. The prices below are Kalshi last trades from August 10:
- Josh O’Connor (9¢) – the quiet steamer. Challengers and The Mastermind made him a prestige leading man, and traders price him above several bookmaker regulars.
- Aaron Pierre (9¢) – the Rebel Ridge breakout has real momentum, though fronting DC’s Lanterns raises the same franchise-conflict question that sank Holland.
- Tom Blyth (5¢) – The Hunger Games: The Ballad of Songbirds and Snakes proved he can carry a studio tentpole; age and passport both fit the brief.
Below those three, the roster thins out fast: George MacKay (added to the exchange July 30), Damson Idris, Nicholas Hoult, and Charlie Hunnam all trade at a few cents, while the perennials Idris Elba (5¢) and Tom Hardy (3¢) persist as sentiment plays a decade past their windows. Treat anything in this tier as entertainment-budget money: the hit rate is tiny, but this is the tier where one afternoon of screen-test leaks can return twentyfold.
Beyond the Casting Market: Other 007 Boards
The actor market is the main event, but the Bond 26 betting ecosystem now has undercards. The liveliest is the theme song: William Hill prices Olivia Dean at evens to record the next Bond theme after her BRIT Awards sweep, ahead of Raye at 7/2, Lana Del Rey at 4/1, Dua Lipa at 7/1, and Harry Styles at 10/1. Kalshi has run companion markets on the villain, the Bond girl, and the theme artist as well, and expect all of these boards to explode with volume the moment the lead is announced. If this kind of pop-culture wagering is your thing, our breakdown of the Stranger Things death odds shows the same market mechanics applied to television, and our prediction markets hub covers how event contracts work in general.
5 Betting Tips for the 007 Endgame
Betting on Bond is a long game of timing, rumors, and market psychology, but the endgame compresses everything. With screen tests this month and an announcement window that closes with the year, the next few months will move faster than the last few years combined. Here is how to play it without donating your bankroll to the books.
Tip 1: Separate Money Moves From Information Moves
The two biggest odds shifts of the summer were opposites. Partridge’s 3/1 entry and Cavill’s 20/1-to-3/1 collapse were both volume-driven, and both drifted or stalled once the money slowed. Turner’s original October surge, by contrast, tracked actual reporting and never reversed.
The quick test before you chase any move:
- Did a named outlet report something, or did a price just move?
- Did the prediction markets move with the book, or shrug?
- Is the actor connected to the actual process (tests, meetings), or just to coverage?
If it fails all three, you are buying someone else’s enthusiasm at a markup.
Tip 2: Bet the Process, Not the Fancast
The names with documented process links (screen-test reporting, wishlist sourcing, casting-office meetings) are Turner, Dickinson, Elordi, Francis, and historically Rose-Marsh. The names running mostly on public affection are Cavill, Elba, Hardy, and the nostalgia tier. Every cycle, the second group soaks up retail money and the first group produces the answer. Craig himself was a process pick the public hated right up until Casino Royale opened.
Tip 3: Use the Deadline Mechanics
Because Polymarket’s contracts expire December 31, its prices carry timing risk the bookmaker odds do not. If you think the announcement slips to 2027, the value play there is the no-announcement contract near 22 cents, not any actor. If you think Pascal’s end-of-year signal is real, actor prices on a deadline market are structurally cheap relative to the books. Understanding which question each venue is answering is worth more than any hot tip.
Tip 4: Spread Small, Don’t Average Up
A sensible structure for this market is one core position on a process-linked name at a fair price, plus one or two long-shot darts from the wild-card tier. What you should not do is keep adding to a favorite as the price shortens; an 11/10 favorite in a sealed-shortlist race is exactly the kind of position that looks smart daily and loses once. The books win novelty markets on margin (that 136 percent board adds up fast), so the fewer, better-priced positions you hold, the less of that margin you pay.
Tip 5: Keep It Fun, Keep Limits Tight
This is a speculation market about a movie casting. Treat it like a night out, not an investment thesis: set a small budget, spread it thin, and let the result be entertainment either way. And if the line between fun and chasing ever blurs, our responsible gambling resources are one click away in the box below.
Conclusion: The Name’s Still Anyone’s
For the first time since Daniel Craig hung up the tux, this market has a shape: a favorite with real staying power in Callum Turner, a documented finalist process, and a public deadline. That makes August through December 2026 the most consequential stretch in the history of next-Bond betting. Either the screen tests leak and the board resolves early, or Amazon keeps the secret and the announcement lands like a thunderclap sometime before New Year’s.
Our read of the board today: Turner at 11/10 is legitimate but fully priced, Dickinson at 8/1 is the value among the process names, the Kalshi-books gap makes Elordi at 12/1 the sneaky play, and Cavill at 3/1 is the trap the market built this month. The wild-card tier (Francis, O’Connor, Pierre) is where a single leak mints winners.
However it breaks, remember what this summer already proved twice: prices in this market move on money as often as they move on truth. Check what the reporting actually says, check what the other venues think, and never let a surging line talk you into someone else’s bet.
We will update this page when the screen-test reports land, and again the moment Amazon MGM makes it official. Until then: bet smart, play light, and keep your martinis cold.
Shaken, not stirred.
Play Safe: Gambling should be fun, not stressful. Set limits, stick to your budget, and never chase losses. If you or someone you know has a gambling problem, call 1-800-MY-RESET or visit ncpgambling.org. For more resources, see our Responsible Gambling page.
Next James Bond Odds FAQ
The questions we get most about the 007 casting race, answered with the latest market data.
Who is the favorite to be the next James Bond right now?
Callum Turner is the favorite everywhere the race is priced: 11/10 at William Hill as of August 6, 2026, about 35 cents on Kalshi, and about 23 percent on Polymarket. He took over the top spot in October 2025 and has held it through every market refresh since, though no casting decision has been announced.
Has the next James Bond actually been announced yet?
No. As of August 10, 2026 there is no official casting announcement. Finalist screen tests were reportedly scheduled for August 2026, and producer Amy Pascal said in early August that an announcement by the end of 2026 is a good bet, with production planned for 2027.
Why did Henry Cavill’s Bond odds suddenly get so short?
A surge of bets, not a casting report. William Hill cut Cavill from 20/1 to 3/1 on August 6, 2026 and attributed the move entirely to betting volume, calling it one of the biggest moves it has seen in this market. Prediction-market traders never followed, still pricing him around 4 or 5 percent, which suggests the move reflects fan money rather than new information.
Can I bet on the next James Bond at a US sportsbook?
No. Licensed US sportsbooks do not offer markets on movie castings, so the fixed odds you see quoted come from UK bookmakers like William Hill. The US-accessible alternative is event contracts on regulated prediction markets: Kalshi runs yes-or-no contracts on more than two dozen candidates, and Polymarket prices the race as well.
Is Tom Holland still in the running to play Bond?
The market says no. Reports in October 2025 claimed his Spider-Man contract bars him from taking a competing franchise lead role, and while that has never been officially confirmed, his price has collapsed to roughly 2 percent on Polymarket. Holland himself has called Bond the pinnacle for a young British actor while deflecting the casting question.
